BSE filing, NSE: RELIGARE. Summary written from the filing by ALFA Finder's alert engine.
Religare Enterprises Ltd: key numbers
- Share price
- ₹232.77
- Market cap
- ₹8,025 Cr
- Revenue (annual)
- ₹8,459 Cr
- Net profit (annual)
- ₹85.96 Cr
- P/E (TTM)
- 345.9×Sector 20.3×
- Promoter holding
- 31.26%+0.70% QoQ
- FII holding
- 9.76%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Religare Enterprises Ltd
All →Religare Enterprises Credit Rating
Religare Enterprises disclosed that CRISIL upgraded credit ratings for its subsidiary Religare Broking's Rs. 500 Crore bank facilities. Long-term rating moved to BBB+/Stable and short-term to A2+.
Religare Enterprises Debt & Borrowing: ₹150 Cr
Care Health Insurance, a material subsidiary of Religare, allotted listed subordinated debentures worth ₹150 Crore at a 10.50% coupon. The debentures mature in 2036, callable after five years.
- Value
- ₹150.0 Cr
Religare Enterprises Management Change
Religare Enterprises appointed Ms. Dipti Jayesh Khandelwal as Company Secretary and Compliance Officer w.e.f. October 31, 2026. She was designated as a Key Managerial Personnel.
Religare Enterprises Other Announcement
Religare Enterprises has filed its quarterly shareholding pattern for the period ending September 30, 2026, as per SEBI Regulation 31(1)(b).
Religare Enterprises Employee Stock Options
Religare Enterprises allotted 22,000 equity shares upon exercise of employee stock options. This allotment increases the company's issued and paid-up equity capital.
Religare Enterprises Management Change
Religare disclosed Mr. Gaurav Sharma as CTO of subsidiary Religare Finvest, effective October 6, 2026. He brings ~30 years of fintech experience from IIFL and L&T Financial.
Other board meeting date announcements
All →Phyto Chem (India) Board Meeting Date
Phyto Chem India intimated a board meeting on 14-11-2026 to consider unaudited financial results for Q2 and half year ended 30-09-2026. The trading window stays closed until 48 hours after results are announced.
Crescentis Capital Board Meeting Date
Crescentis Capital Ltd intimated BSE of a board meeting on 12 November 2026 to approve Q2 and half-year unaudited results. It also notes the trading window stays closed until 48 hours after results.
GVP Infotech Board Meeting Date
GVP Infotech will hold a board meeting on 18 November 2026 to consider unaudited half-yearly results. Trading window closes until 20 November 2026.
Viaz Tyres Board Meeting Date
Viaz Tyres will hold a board meeting on 13 November 2026 to consider unaudited half-yearly results. Trading window closes until 15 November 2026.
Cindrella Hotels Board Meeting Date
Cindrella Hotels intimated a board meeting on 14 November 2026 to consider unaudited results for the quarter ended 30 September 2026. This is advance notice; the results are not yet approved.
Moksh Ornaments Board Meeting Date
Moksh Ornaments Limited has intimated a board meeting on 14 November 2026 to consider unaudited standalone quarterly results for September 2026 and other business. Trading window is closed from 1 October to 16 November 2026.